The TNNI3 Gene Cardiomyopathy Familial Hypertrophic Type 7 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the TNNI3 gene, which are known to be a cause of Familial Hypertrophic Cardiomyopathy (FHC) type 7. FHC is a condition characterized by the thickening of the heart's muscle, which can lead to various cardiac issues, including heart failure and arrhythmias. The TNNI3 gene plays a crucial role in the heart muscle's contraction mechanism, and mutations in this gene can disrupt normal heart function, leading to the development of hypertrophic cardiomyopathy.
The test is particularly important for individuals with a family history of hypertrophic cardiomyopathy or related symptoms, as it can provide vital information for diagnosis, treatment, and management of the condition. Additionally, it can be used for predictive testing in asymptomatic family members to assess their risk of developing the condition.
The cost of the TNNI3 Gene Cardiomyopathy Familial Hypertrophic Type 7 Genetic Test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the TNNI3 gene. The results from this test can help guide clinical decisions, including surveillance and preventive measures for affected individuals and their families.
The MYL3 Gene Cardiomyopathy Familial Hypertrophic Type 8 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the MYL3 gene, which are associated with familial hypertrophic cardiomyopathy (HCM) type 8. This condition is a form of heart disease that is inherited in an autosomal dominant pattern, where the heart muscle becomes abnormally thick, making it harder for the heart to pump blood. The MYL3 gene plays a crucial role in encoding the myosin light chain, a component essential for the contraction of heart muscles.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab. This sample is then analyzed in the lab to detect any genetic variations that may indicate a predisposition to this form of cardiomyopathy. Early detection through this genetic test can be pivotal in managing the condition, allowing for timely interventions and personalized treatment plans to mitigate the risk of complications such as heart failure or sudden cardiac death.
DNA Labs UAE, known for its state-of-the-art facilities and expert team, ensures a reliable and efficient testing process, providing crucial information for individuals with a family history of HCM or those exhibiting symptoms related to the condition. This test not only aids in the diagnosis but also helps in the risk assessment for family members, guiding decisions on the need for further genetic counseling or testing.
The TTN Gene Cardiomyopathy familial hypertrophic type 9 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the TTN gene, which are implicated in familial hypertrophic cardiomyopathy type 9 (FHC9). This condition is a form of heart disease characterized by the thickening of the heart's muscle tissue, leading to a range of symptoms from shortness of breath to heart failure. The TTN gene plays a crucial role in the structure and function of heart muscle, and mutations in this gene can disrupt heart muscle's normal operation, contributing to the development of hypertrophic cardiomyopathy.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic anomalies in the TTN gene. This test is critical for individuals with a family history of hypertrophic cardiomyopathy or related symptoms, as it can provide essential insights into the risk of developing the condition, inform treatment decisions, and guide family planning. Early detection through genetic testing like the TTN Gene Cardiomyopathy familial hypertrophic type 9 Genetic Test can significantly impact the management and prognosis of familial hypertrophic cardiomyopathy, offering a targeted approach to care and surveillance for affected individuals and their families.
The "TNNI3 Gene Cardiomyopathy Familial Restrictive Type 1 Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TNNI3 gene, which are associated with familial restrictive cardiomyopathy type 1 (RCM1). This form of cardiomyopathy is characterized by the heart muscle becoming rigid, limiting the heart's ability to fill properly with blood during the relaxation phase, which can lead to heart failure and other serious complications.
This test is crucial for individuals with a family history of RCM1 or who exhibit symptoms suggestive of restrictive cardiomyopathy, as it can confirm the diagnosis and allow for early intervention and management of the condition. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the TNNI3 gene.
The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. By identifying the genetic basis of the condition, this test not only aids in the diagnosis and treatment of the individual tested but also provides valuable information for family members who may be at risk, enabling them to make informed decisions about their health and preventive care.
The MT-TI gene, known for its crucial role in mitochondrial function, has been linked to certain types of cardiomyopathy, a disease of the heart muscle that can lead to heart failure and other serious conditions. Identifying mutations in the MT-TI gene can be essential for diagnosing mitochondrial cardiomyopathy, enabling targeted treatment and management of the condition.
DNA Labs UAE offers a specialized genetic test to detect mutations in the MT-TI gene, aiding in the diagnosis of cardiomyopathy related to this gene. The test is priced at 4400 AED and is conducted in their state-of-the-art laboratory facilities. By undergoing this test, individuals who have a family history of cardiomyopathy or have symptoms related to heart muscle dysfunction can gain valuable insights into their genetic predisposition towards this condition. Early detection through the MT-TI related genetic test can be critical in managing the disease effectively, potentially improving the quality of life and outcomes for those affected.
The EYA4 gene is associated with a specific type of heart condition known as dilated cardiomyopathy type 1J (DCM1J). This condition is characterized by the dilation and impaired contraction of the left ventricle or both ventricles of the heart, which can lead to heart failure and other complications. Genetic testing for mutations in the EYA4 gene can help in diagnosing this condition, allowing for early intervention and management strategies to be implemented.
At DNA Labs UAE, individuals can undergo a genetic test specifically designed to detect mutations in the EYA4 gene that are linked to dilated cardiomyopathy type 1J. The test is a crucial step for individuals with a family history of the condition or those presenting symptoms suggestive of DCM1J, enabling precise diagnosis and personalized treatment planning.
The cost of the EYA4 Gene Cardiomyopathy Dilated Type 1J Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis required to identify the presence of pathogenic mutations in the EYA4 gene, providing essential information for patients and their healthcare providers regarding the management of the condition.
The MYPN Gene Cardiomyopathy Dilated Type 1KK Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the MYPN gene that are associated with dilated cardiomyopathy (DCM) of type 1KK. This condition is a form of heart disease that affects the heart's ability to pump blood efficiently, leading to enlargement of the heart's chambers and weakened heart muscle. The test is crucial for individuals with a family history of DCM or those showing symptoms of the condition, as early detection can significantly impact management and treatment options. The cost of the test is 4400 AED, which reflects the comprehensive analysis and personalized care that patients receive. By identifying specific genetic mutations, healthcare providers can tailor treatment plans to the individual's genetic makeup, improving outcomes and quality of life for those affected by this condition.
The SGCD Gene Cardiomyopathy Dilated Type 1L Genetic Test is a specialized diagnostic tool used to identify mutations in the SGCD gene, which are associated with Dilated Cardiomyopathy Type 1L (DCM1L). This condition is a form of heart disease that affects the heart's ability to pump blood efficiently, leading to heart enlargement and impaired systolic function. The SGCD gene plays a crucial role in encoding a part of the dystrophin-glycoprotein complex, which is essential for maintaining the integrity and function of muscle cells, including those in the heart.
The test is particularly valuable for individuals with a family history of DCM1L or symptoms suggestive of cardiomyopathy, such as shortness of breath, fatigue, or irregular heartbeats. Early detection through this genetic test can aid in the timely management and treatment of the condition, potentially improving the quality of life and prognosis for affected individuals.
Administered at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates, the test involves a simple blood draw or cheek swab from the patient. The sample is then analyzed for specific mutations in the SGCD gene that are linked to Dilated Cardiomyopathy Type 1L.
The cost of the SGCD Gene Cardiomyopathy Dilated Type 1L Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the comprehensive insight it provides into the genetic basis of cardiomyopathy can be invaluable for affected individuals and their families, offering a pathway to personalized medical care and interventions that can mitigate the impact of the disease.
The "PRDM16 Gene Cardiomyopathy Dilated Type 1LL Genetic Test" is a specialized diagnostic tool used to identify mutations in the PRDM16 gene, which have been associated with Dilated Cardiomyopathy (DCM) type 1LL. DCM is a condition characterized by the enlargement and weakening of the heart's main pumping chamber, leading to decreased heart function and a range of cardiac symptoms. The PRDM16 gene plays a crucial role in cardiac development and function, and mutations in this gene can disrupt normal heart muscle structure and lead to the development of DCM.
This genetic test is vital for individuals with a family history of DCM or those who exhibit symptoms suggestive of this condition, as it allows for the early detection of gene mutations. Early diagnosis can enable timely intervention and management of the disease, potentially improving the quality of life and prognosis for affected individuals.
The test is offered at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. By opting for this test at DNA Labs UAE, patients can expect a comprehensive analysis of the PRDM16 gene, along with professional guidance on the implications of the test results for their health and potential treatment options.
The CSRP3 gene plays a crucial role in the structure and function of the heart muscle. Mutations in the CSRP3 gene are associated with dilated cardiomyopathy type 1M (DCM1M), a genetic disorder that affects the heart's ability to pump blood efficiently. This condition leads to an enlarged and weakened heart, which can result in heart failure and other complications if not diagnosed and managed properly.
To aid in the diagnosis and management of DCM1M, genetic testing for mutations in the CSRP3 gene is available. This test is crucial for individuals with a family history of dilated cardiomyopathy or those exhibiting symptoms of the condition, as it can confirm the diagnosis and guide treatment options. Furthermore, it can also provide valuable information for family planning and the assessment of risk for family members.
In the UAE, DNA Labs UAE offers the CSRP3 Gene Cardiomyopathy Dilated Type 1M Genetic Test. The cost of the test is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the CSRP3 gene. The results of this test can provide critical insights into the patient's condition, enabling personalized treatment plans and helping to improve outcomes for those affected by DCM1M.
